Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Alleviant Medical is raising $6,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Berman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Alleviant Medical

Alleviant Medical is a medical device company developing potential therapies for congestive heart failure. Alleviant medical is focused on developing a novel minimally-invasive device to relieve patient symptoms, improve functional mobility and reduce the frequency of hospital admissions. Their proprietary, single-use transcatheter system enables cardiologists to decompress the heart’s left atrium which is the key driver of heart failure symptoms and hospitalizations. This treatment is expected to lift the burden of heart failure by improving patient symptoms and quality of life, reducing reliance on costly medications and decreasing hospitalization rates.

To learn more about Alleviant Medical, visit http://www.alleviantmedical.com/

Contact:
Adam Berman, Chief Executive Officer
857-776-2154
https://www.linkedin.com/in/adamlberman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved